Júlia Vendrell-Serres
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Júlia Vendrell-Serres has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Amanda Rodríguez-Urrutia
Group of Psychiatry Mental Health and Addictions Vall d'Hebron Research Institute (VHIR) Barcelona Spain
3 shared publications - Josep Antoni Ramos-Quiroga
Hospital Universitari Vall d'Hebron
3 shared publications - Alexandra Vlaic
Department of Psychiatry, Vall d'Hebron Hospital Universitari, Barcelona, Spain
2 shared publications - María Dolores Braquehais
Integral Care Program for Sick Health Professionals, Galatea Clinic, Barcelona, Spain
2 shared publications - María Teresa Alonzo-Castillo
Department of Psychiatry, Vall d'Hebron Hospital Universitari, Barcelona, Spain
2 shared publications - Patricia Laura Maran
Psychiatry, Mental Health and Addictions Group, Vall d'Hebron Research Institute (VHIR), Instituto de Investigación Sanitaria Acreditado Instituto de Investigación - Hospital Universitario Vall d'Hebron (IR-HUVH), Barcelona, Catalonia, Spain
2 shared publications
Latest Publications
- Open Access
- 22 October 2025
- Published by JMIR Publications Inc. in JMIR Mental Health
- Vol. 12 (1) , e67802
Performance of Automatic Speech Analysis in Detecting Depression: Systematic Review and Meta-Analysis
Background: Despite the high prevalence and significant burden of depression, underdiagnosis remains a persistent challenge. Automatic speech analysis (ASA) has emerged as a promising method for depression assessment. However, a comprehensive quantitative synthesis evaluating its diagnostic accuracy is still lacking. Objective: This systematic review and meta-analysis aimed to assess the diagnostic performance of ASA in detecting depression, considering both machine learning and deep learning approaches. Methods: We conducted a systematic search across 8 databases, including MEDLINE, PsycInfo, Embase, CINAHL, IEEE Xplore, ACM Digital Library, Scopus, and Google Scholar from January 2013 to April 1, 2025. We included studies published in English that evaluated the accuracy of ASA for detecting depression, and reported performance metrics such as accuracy, sensitivity, specificity, precision, or confusion matrices. Study quality was assessed using a modified version of the Quality Assessment of Studies of Diagnostic Accuracy-Revised. A 3-level meta-analysis was performed to estimate the pooled highest and lowest accuracy, sensitivity, specificity, and precision. Meta-regressions and subgroup analyses were performed to explore heterogeneity across various factors, including type of publication, artificial intelligence algorithms, speech features, speech-eliciting tasks, ground truth assessment, validation approach, dataset, dataset language, participants’ mean age, and sample size. Results: Of the 1345 records identified, 105 studies met the inclusion criteria. The pooled mean of the highest accuracy, sensitivity, specificity, and precision were 0.81 (95% CI 0.79 to 0.83), 0.84 (95% CI 0.81 to 0.86), 0.83 (95% CI 0.79 to 0.86), and 0.81 (95% CI 0.77 to 0.84), respectively, whereas the pooled mean of the lowest accuracy, sensitivity, specificity, and precision were 0.66 (95% CI 0.63 to 0.69), 0.63 (95% CI 0.58 to 0.68), 0.60 (95% CI 0.55 to 0.66), and 0.64 (95% CI 0.58 to 0.70), respectively. Conclusions: ASA shows promise as a method for detecting depression, though its readiness for clinical application as a standalone tool remains limited. At present, it should be regarded as a complementary method, with potential applications across diverse contexts. Further high-quality, peer-reviewed studies are needed to support the development of robust, generalizable models and to advance this emerging field. Trial Registration: PROSPERO CRD42023444431; https://www.crd.york.ac.uk/PROSPERO/view/CRD42023444431
- 22 October 2025
- Published by JMIR Publications Inc. in JMIR Mental Health
- Vol. 12 (1) , e67802
Open AccessPerformance of Automatic Speech Analysis in Detecting Depression: Systematic Review and Meta-Analysis
Background: Despite the high prevalence and significant burden of depression, underdiagnosis remains a persistent challenge. Automatic speech analysis (ASA) has emerged as a promising method for depression assessment. However, a comprehensive quantitative synthesis evaluating its diagnostic accuracy is still lacking. Objective: This systematic review and meta-analysis aimed to assess the diagnostic performance of ASA in detecting depression, considering both machine learning and deep learning approaches. Methods: We conducted a systematic search across 8 databases, including MEDLINE, PsycInfo, Embase, CINAHL, IEEE Xplore, ACM Digital Library, Scopus, and Google Scholar from January 2013 to April 1, 2025. We included studies published in English that evaluated the accuracy of ASA for detecting depression, and reported performance metrics such as accuracy, sensitivity, specificity, precision, or confusion matrices. Study quality was assessed using a modified version of the Quality Assessment of Studies of Diagnostic Accuracy-Revised. A 3-level meta-analysis was performed to estimate the pooled highest and lowest accuracy, sensitivity, specificity, and precision. Meta-regressions and subgroup analyses were performed to explore heterogeneity across various factors, including type of publication, artificial intelligence algorithms, speech features, speech-eliciting tasks, ground truth assessment, validation approach, dataset, dataset language, participants’ mean age, and sample size. Results: Of the 1345 records identified, 105 studies met the inclusion criteria. The pooled mean of the highest accuracy, sensitivity, specificity, and precision were 0.81 (95% CI 0.79 to 0.83), 0.84 (95% CI 0.81 to 0.86), 0.83 (95% CI 0.79 to 0.86), and 0.81 (95% CI 0.77 to 0.84), respectively, whereas the pooled mean of the lowest accuracy, sensitivity, specificity, and precision were 0.66 (95% CI 0.63 to 0.69), 0.63 (95% CI 0.58 to 0.68), 0.60 (95% CI 0.55 to 0.66), and 0.64 (95% CI 0.58 to 0.70), respectively. Conclusions: ASA shows promise as a method for detecting depression, though its readiness for clinical application as a standalone tool remains limited. At present, it should be regarded as a complementary method, with potential applications across diverse contexts. Further high-quality, peer-reviewed studies are needed to support the development of robust, generalizable models and to advance this emerging field. Trial Registration: PROSPERO CRD42023444431; https://www.crd.york.ac.uk/PROSPERO/view/CRD42023444431
- Open Access
- 23 October 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Performance of Automatic Speech Analysis in Detecting Depression: Systematic Review and Meta-Analysis (Preprint)
BACKGROUND Despite the high prevalence and significant burden of depression, underdiagnosis remains a persistent challenge. Automatic speech analysis (ASA) has emerged as a promising method for depression assessment. However, a comprehensive quantitative synthesis evaluating its diagnostic accuracy is still lacking. OBJECTIVE This systematic review and meta-analysis aimed to assess the diagnostic performance of ASA in detecting depression, considering both machine learning and deep learning approaches. METHODS We conducted a systematic search across 8 databases, including MEDLINE, PsycInfo, Embase, CINAHL, IEEE Xplore, ACM Digital Library, Scopus, and Google Scholar from January 2013 to April 1, 2025. We included studies published in English that evaluated the accuracy of ASA for detecting depression, and reported performance metrics such as accuracy, sensitivity, specificity, precision, or confusion matrices. Study quality was assessed using a modified version of the Quality Assessment of Studies of Diagnostic Accuracy-Revised. A 3-level meta-analysis was performed to estimate the pooled highest and lowest accuracy, sensitivity, specificity, and precision. Meta-regressions and subgroup analyses were performed to explore heterogeneity across various factors, including type of publication, artificial intelligence algorithms, speech features, speech-eliciting tasks, ground truth assessment, validation approach, dataset, dataset language, participants’ mean age, and sample size. RESULTS Of the 1345 records identified, 105 studies met the inclusion criteria. The pooled mean of the highest accuracy, sensitivity, specificity, and precision were 0.81 (95% CI 0.79 to 0.83), 0.84 (95% CI 0.81 to 0.86), 0.83 (95% CI 0.79 to 0.86), and 0.81 (95% CI 0.77 to 0.84), respectively, whereas the pooled mean of the lowest accuracy, sensitivity, specificity, and precision were 0.66 (95% CI 0.63 to 0.69), 0.63 (95% CI 0.58 to 0.68), 0.60 (95% CI 0.55 to 0.66), and 0.64 (95% CI 0.58 to 0.70), respectively. CONCLUSIONS ASA shows promise as a method for detecting depression, though its readiness for clinical application as a standalone tool remains limited. At present, it should be regarded as a complementary method, with potential applications across diverse contexts. Further high-quality, peer-reviewed studies are needed to support the development of robust, generalizable models and to advance this emerging field. CLINICALTRIAL PROSPERO CRD42023444431; https://www.crd.york.ac.uk/PROSPERO/view/CRD42023444431
- 23 October 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPerformance of Automatic Speech Analysis in Detecting Depression: Systematic Review and Meta-Analysis (Preprint)
BACKGROUND Despite the high prevalence and significant burden of depression, underdiagnosis remains a persistent challenge. Automatic speech analysis (ASA) has emerged as a promising method for depression assessment. However, a comprehensive quantitative synthesis evaluating its diagnostic accuracy is still lacking. OBJECTIVE This systematic review and meta-analysis aimed to assess the diagnostic performance of ASA in detecting depression, considering both machine learning and deep learning approaches. METHODS We conducted a systematic search across 8 databases, including MEDLINE, PsycInfo, Embase, CINAHL, IEEE Xplore, ACM Digital Library, Scopus, and Google Scholar from January 2013 to April 1, 2025. We included studies published in English that evaluated the accuracy of ASA for detecting depression, and reported performance metrics such as accuracy, sensitivity, specificity, precision, or confusion matrices. Study quality was assessed using a modified version of the Quality Assessment of Studies of Diagnostic Accuracy-Revised. A 3-level meta-analysis was performed to estimate the pooled highest and lowest accuracy, sensitivity, specificity, and precision. Meta-regressions and subgroup analyses were performed to explore heterogeneity across various factors, including type of publication, artificial intelligence algorithms, speech features, speech-eliciting tasks, ground truth assessment, validation approach, dataset, dataset language, participants’ mean age, and sample size. RESULTS Of the 1345 records identified, 105 studies met the inclusion criteria. The pooled mean of the highest accuracy, sensitivity, specificity, and precision were 0.81 (95% CI 0.79 to 0.83), 0.84 (95% CI 0.81 to 0.86), 0.83 (95% CI 0.79 to 0.86), and 0.81 (95% CI 0.77 to 0.84), respectively, whereas the pooled mean of the lowest accuracy, sensitivity, specificity, and precision were 0.66 (95% CI 0.63 to 0.69), 0.63 (95% CI 0.58 to 0.68), 0.60 (95% CI 0.55 to 0.66), and 0.64 (95% CI 0.58 to 0.70), respectively. CONCLUSIONS ASA shows promise as a method for detecting depression, though its readiness for clinical application as a standalone tool remains limited. At present, it should be regarded as a complementary method, with potential applications across diverse contexts. Further high-quality, peer-reviewed studies are needed to support the development of robust, generalizable models and to advance this emerging field. CLINICALTRIAL PROSPERO CRD42023444431; https://www.crd.york.ac.uk/PROSPERO/view/CRD42023444431
- Open Access
- 6 September 2023
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 22 (1) , 159-168
Treating Treatment-resistant Depression with Esketamine Nasal Spray When All Therapeutic Options Have Been Exhausted: Clinical Experience from a Spanish Cohort of Expanded Use
Júlia Vendrell-Serres, Óscar Soto-Angona, Amanda Rodríguez-Urrutia, Benedetta Inzoli, Antonia López González, Josep Antoni Ramos-Quiroga. Clin Psychopharmacol Neurosci 2024;22:159-68. https://doi.org/10.9758/cpn.23.1097
- 6 September 2023
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 22 (1) , 159-168
Open AccessTreating Treatment-resistant Depression with Esketamine Nasal Spray When All Therapeutic Options Have Been Exhausted: Clinical Experience from a Spanish Cohort of Expanded Use
Júlia Vendrell-Serres, Óscar Soto-Angona, Amanda Rodríguez-Urrutia, Benedetta Inzoli, Antonia López González, Josep Antoni Ramos-Quiroga. Clin Psychopharmacol Neurosci 2024;22:159-68. https://doi.org/10.9758/cpn.23.1097